Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells

Cytokine

Volumn 19, Issue 4, 2002, Pages 159-174

  Hsieh, Hsian Guey ^a,b   Loong, Che Chuang ^a,b   Lin, Ching Yuang ^a,b,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Interleukin 17; MAPK cascades; Mitogen activated protein kinase (MAPK); PP2; Renal epithelial cells; Src; Src kinase; Tyrosyl phosphorylation

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY ALLOGRAFT; KIDNEY CELL; KIDNEY EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

EID: 0036389802     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.1952     Document Type: Article

References (33)

1. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY (2001) IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int (in press).
2. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecqu E (1996) Interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593-2603.
3. Kennedy J, Rossi DL, Zurawski SM, Vega F, Jr., Kastelein RA, Wagner JL, Hannum CH, Zlotnik A (1996) IL-17: A cytokine preferentially expressed by 33TCR+CD43CD83 T cells. J Interferon Cytokine Res 16:611-617.
4. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811-821.
5. Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR (1998) Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 9:1526-1534.
6. Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional di3erentiation of dendritic cell progenitors. J Immunol 162:577-584.
7. Lin Y, Kirby JA, Browell DA, Morley AR, Shenton BK, Proud G, Taylor RM (1993) Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cells. Clin Exp Immunol 92:145-151.
8. Miller SM, Gupta R, Lee SH, Belitsky P (1989) Renal allograft rejection induces MHC class II upregulation in autologous kindey an liver of the recipient. Transpl Proceed 21:328.
9. Kirby JA, Rajasekar MR, Lin Y, Proud G, Taylor RM (1993) Interaction between T lymphocytes and kidney epithelial cells during renal allograft rejection. Kid Inter-Suppl 39:S124-128.
10. Albanesi C, Cavani A, Girolomoni G (1999) IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162:494-502.
11. Teunissen MB, Koomen CW, De Waal Malefyt R, Wierenga EA, Bos JD (1998) Interelukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermat 111:645-649.
12. Shalom-Barak T, Quach J, Lotz M (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappa B. J Biol Chem 273:27467-27773.
13. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP (1999) Mitogen-activated protein kinase and nuclear factor kappa B together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arth Rheum 42:2399-2409.
14. Awane M, Anders PG, Li DJ, Reinecker HC (1999) NF-kappa B-inducing kinase is a common mediator of IL-17, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162:5337-5344.
15. Schwandner R, Yamaguchi K, Cao Z (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF) 6 in interleukin 17 signal transduction. J Exp Med 191:1233-1239.
16. Subramaniam SV, Perason LL, Adunyah SE (1999) Interleukin-17 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937. Bioche Biophy Res Commun 259:172-177.
17. Subramaniam SV, Cooper RS, Adunyah SE (1999) Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Bioche Biophy Res Commun 262:14-19.
18. Leaman DW, Leung S, Li X, Stark GR (1996) Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588.
19. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR (1996) Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol 157:3381-3390.
20. Xia Z, Dickens M, Raingeaud J, David RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
21. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR, Ahmad MFX, Avruch J (1994) The stress-activated protein kinase subfamily of c-jun kinase. Nature 369:156-160.
22. Huwiler A, Van Rossum G, Wartmann M, Pfeilschifter J (1998) An giotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype. Eur J Pharmacol 343:297-302.
23. Abram CL, Courtneidge SA (2000) Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254:1-13.
24. Nagao M, Kaziro Y, Itoh H (1999) The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Galpha12. Oncogene 18:4425-4434.
25. Mocasi A, Jakus Z, Vantus T, Berton G, Lowell CA, Ligeti E (2000) Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 164:4321-4331.
26. Rush D, Jeffery J, Trpkov K, Solez K, Gough J (1996) Effect of subclinical rejection on renal allograft histology and funciton at 6 months. Transplant Pro 28:494-495.
27. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J (1994) Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57:208-211.
28. Rush DN, Jerry JR, Gough J (1995) Sequential protocol biopsies in renal transplant patients. Transplantation 59:511-514.
29. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA (1996) Discovery of a novel, potent and src family-selective tyrosine kinase inhibitor: study of Lck- and Fyn T-dependent T cell activation. J Biol Chem 271:695-701.
30. L expression and reverse the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18:4654-4662.
31. Sirianni R, Sirianni R, Curr BR, Pezzi V, Rainey WE (2001) A role for src tyrosine kinase in regulating adrenal aldosterone production. J Molecular Endocrinology 26:207-215.
32. Lann M, Lötvall J, Chung KF, Lindén (2001) IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. British J Pharmacology 133:200-206.
33. Woltman AM, De HS, Boonstra JG, Gohin SJ, Daha MR, Van KC (2000) Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J American Society of Nephrology 11:2044-2055.